v
Acquisitions
May 26, 2026
•
9 min read
Re-entering the vaccine market with multiple sclerosis (MS) upside
Frontiers in Medicine
May 24, 2026
24 min read
How Dr. Georg Schett sparked renaissance in autoimmune disease
Weekly Readout
May 22, 2026
22 min read
Weekly Readout #8: Week ending May 22, 2026
May 20, 2026
8 min read
A founder-led startup aiming to solve gene therapy's "last mile" problem
May 16, 2026
25 min read
Beyond autologous CAR-T: allogeneic, in vivo, and T-cell engagers (TCE)
May 15, 2026
20 min read
Weekly Readout #7: Week of May 11, 2026
May 9, 2026
Immunology Civil War, the discovery of T-cells, and their rebirth as medicines
May 8, 2026
Week of May 4, 2026
May 6, 2026
11 min read
A long-acting diabetic eye disease play
May 4, 2026
Scooping a reverse merger for a TCE pipeline
May 1, 2026
26 min read
Evolution of treatments: from dark age to golden age
13 min read
Week of April 27, 2026
Apr 29, 2026
An oral HAE play
Apr 27, 2026
19 min read
A differentiated JAK play
Apr 26, 2026
23 min read
Societal perception, recognition as a disease, and the discovery of its hormonal & genetic drivers
Apr 24, 2026
18 min read
Week of April 20, 2026
Apr 21, 2026
Digging into the in vivo CAR-T gold rush
Apr 17, 2026
Week of April 13, 2026
Apr 15, 2026
A bet on dual-payload ADCs
Apr 10, 2026
14 min read
Week of April 6, 2026
Apr 7, 2026
The advent of 3rd generation ADCs
Apr 6, 2026
10 min read
The story of the first FDA approved drug for Prader-Willi Syndrome (PWS) in patients four years of age and older
Apr 5, 2026
Rise of selective OX2 agonists for narcolepsy
Apr 3, 2026
Week of March 30, 2026
Apr 1, 2026
1 min read
Highlighting biotech innovation every week.
